Porous activated carbon was modified with (1 E ,2 E )-1,2-bis(pyridin-4-ylmethylene)hydrazine (M) and (1 E ,2 E )-1,2-bis(pyridin-3-ylmethylene)hydrazine (SCH-4).
No takes yet. Share an insight, caveat, or question.
Ghaedi et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: